AeroVironment Inc Reports Record Q4 Revenue

By Greg Peters • Wednesday, June 25 06:02 • Permanent Link

AeroVironment, Inc. (NASDAQ: AVAV) has reported its financial results for the fiscal fourth quarter and year ended April 30, 2025. The company's performance in the fourth quarter and fiscal year includes several noteworthy highlights:

Record fourth quarter revenue of $275.1 million and fiscal year revenue of $820.6 million, up 40% and 14% year-over-year, respectively.
Fourth quarter and fiscal year net income of $16.7 million and $43.6 million, respectively, and record fourth quarter and fiscal year non-GAAP adjusted EBITDA of $61.6 million and $146.4 million, respectively.
Record fiscal year bookings of $1.2 billion, indicating strong demand and strategic wins.

The revenue for the fourth quarter of fiscal 2025 saw a significant increase of 40% compared to the fourth quarter of fiscal 2024, primarily driven by higher product sales. Gross margin for the same period increased by 33% compared to the prior year's fourth quarter.

However, the fiscal 2025 fourth quarter was negatively impacted by non-cash UGV goodwill impairment charges of $18.4 million, which affected the net income.

Looking ahead to fiscal year 2026, inclusive of the projected results of the BlueHalo acquisition, the company expects revenue of between $1.9 billion and $2.0 billion, non-GAAP adjusted EBITDA of between $300 million and $320 million, and non-GAAP earnings per diluted share of between $2.80 and $3.00.

The company's funded backlog as of April 30, 2025, stood at $726.6 million, compared to $400.2 million as of April 30, 2024, indicating a substantial increase.

The market has reacted to these announcements by moving the company's shares 0.55% to a price of $192.28. For the full picture, make sure to review AeroVironment Inc's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.